ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 572,99
-0,78%
Dow Jones
40 391,88
0,45%
DAX
18 495,56
-0,56%
Brent Oil
83,08
-1,49%
Bitcoin
63 781,81
-1,65%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Summit Therapeutics Inc (SMMT)

  7. Summit Therapeutics Inc (SMMT) Actualités

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateHeureSourceTitreSymboleSociété
10/03/201601h46GlobeNewswire Inc.Summit Therapeutics Supports Ninth Annual Rare Disease DayNASDAQ:SMMTSummit Therapeutics Inc
10/03/201601h46GlobeNewswire Inc.Summit Therapeutics Announces Publication of Preclinical Data Showing Ridinilazole Outperformed Standard of Care in Reducing ...NASDAQ:SMMTSummit Therapeutics Inc
07/03/201622h17Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
17/02/201613h00GlobeNewswire Inc.Summit Therapeutics to Participate in SunTrust Robinson Humphrey’s 2016 Orphan Drug DayNASDAQ:SMMTSummit Therapeutics Inc
16/02/201619h20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SMMTSummit Therapeutics Inc
03/02/201613h00GlobeNewswire Inc.Summit Therapeutics to Present at 18th Annual BIO CEO & Investor ConferenceNASDAQ:SMMTSummit Therapeutics Inc
21/01/201613h00GlobeNewswire Inc.Summit Therapeutics Receives Regulatory Approval to Initiate PhaseOut DMD, a Phase 2 Clinical Trial of SMT C1100 in Patients ...NASDAQ:SMMTSummit Therapeutics Inc
19/01/201613h00GlobeNewswire Inc.Summit Therapeutics Granted Key European Patent for Novel Antibiotic Ridinilazole for Treatment of C. Difficile InfectionNASDAQ:SMMTSummit Therapeutics Inc
17/12/201513h00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Third Quarter Ended 31 October 2015 and Operational ProgressNASDAQ:SMMTSummit Therapeutics Inc
14/12/201513h00GlobeNewswire Inc.Summit Therapeutics to Report Financial Results for the Third Quarter Ended 31 October 2015 on 17 December 2015NASDAQ:SMMTSummit Therapeutics Inc
10/12/201513h00GlobeNewswire Inc.Summit Therapeutics to Participate in the JMP Securities DMD ForumNASDAQ:SMMTSummit Therapeutics Inc
03/12/201513h00GlobeNewswire Inc.Summit Therapeutics to Present at the 26th Annual Oppenheimer Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
02/12/201513h00GlobeNewswire Inc.Summit Therapeutics Announces First Milestone Achieved in Strategic Alliance With University of Oxford for Future Generation ...NASDAQ:SMMTSummit Therapeutics Inc
25/11/201513h00GlobeNewswire Inc.Summit Therapeutics to Present at the Piper Jaffray 27th Annual Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
23/11/201513h00GlobeNewswire Inc.Summit Therapeutics Announces Novel Antibiotic Ridinilazole (SMT19969) Achieves Statistical Superiority Over Vancomycin in Co...NASDAQ:SMMTSummit Therapeutics Inc
17/11/201513h00GlobeNewswire Inc.Summit Therapeutics and the University of Oxford Announce Multi-Year Extension of Strategic Alliance for Development of Utrop...NASDAQ:SMMTSummit Therapeutics Inc
30/09/201513h00GlobeNewswire Inc.Summit Therapeutics Presents Additional Data From Phase 1b Modified Diet Clinical Trial of SMT C1100 in DMD Patients at WMSNASDAQ:SMMTSummit Therapeutics Inc
24/09/201513h00GlobeNewswire Inc.Summit Therapeutics to Present Phase 1b Clinical and Preclinical DMD Data at the 20th International Congress of the World Mus...NASDAQ:SMMTSummit Therapeutics Inc
22/09/201502h46GlobeNewswire Inc.Summit Therapeutics Completes Targeted Enrolment for SMT19969 Phase 2 Trial for C. difficile InfectionNASDAQ:SMMTSummit Therapeutics Inc
07/05/201523h20Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:SMMTSummit Therapeutics Inc
06/05/201513h34GlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Fiscal Year Ended 31 January 2015NASDAQ:SMMTSummit Therapeutics Inc
01/05/201508h00GlobeNewswire Inc.Summit Therapeutics Provides Notice of Full Year Financial ResultsNASDAQ:SMMTSummit Therapeutics Inc
30/04/201523h34Analyst Ratings NetworkSummit Therapeutic Stock Rating Reaffirmed by Zacks (SMMT)NASDAQ:SMMTSummit Therapeutics Inc
30/04/201513h00GlobeNewswire Inc.Summit Therapeutics Granted Key Patent for Novel Antibiotic SMT19969 for the Treatment of C. Difficile InfectionNASDAQ:SMMTSummit Therapeutics Inc
07/04/201513h00GlobeNewswire Inc.Summit to Present at Needham and Company's Annual Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
26/03/201518h27Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
18/03/201519h15GlobeNewswire Inc.Summit Therapeutics Announces Exercise of Over-Allotment OptionNASDAQ:SMMTSummit Therapeutics Inc
11/03/201522h00Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SMMTSummit Therapeutics Inc
10/03/201517h45Business WireSummit Therapeutics Announces Closing of Its U.S. Initial Public OfferingNASDAQ:SMMTSummit Therapeutics Inc
09/03/201518h29Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT

Dernières Valeurs Consultées

BIBX
INSTARBTC
INSTAR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés